Stockscreener 앱 받기
205.07
0.56%
-1.16
시장 영업 전:
205.25
0.18
+0.09%
Abbvie Inc 주식(ABBV)의 최신 뉴스
AbbVie Inc. $ABBV Shares Acquired by Procyon Advisors LLC - MarketBeat
MassMutual Private Wealth & Trust FSB Has $39.20 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
CWA Asset Management Group LLC Purchases 11,964 Shares of AbbVie Inc. $ABBV - MarketBeat
Aventura Private Wealth LLC Takes $2.14 Million Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Stock Slides as Insider Selling Spooks Investors - TipRanks
AbbVie Inc. $ABBV Shares Sold by TruWealth Advisors LLC - MarketBeat
Neville Rodie & Shaw Inc. Has $23.31 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Is AbbVie Inc. (ABBV) one of the debt free halal stocks to buy? - MSN
If You Invested $1,000 in Abbvie Inc (ABBV) - Stock Titan
The Smartest Dividend ETF to Buy With $1,000 Right Now - The Motley Fool
Union Bancaire Privee UBP SA Boosts Stake in AbbVie Inc. $ABBV - MarketBeat
Park National Corp OH Sells 10,959 Shares of AbbVie Inc. $ABBV - MarketBeat
Hudson Bay Capital Management LP Buys 13,466 Shares of AbbVie Inc. $ABBV - MarketBeat
Coastline Trust Co Buys 10,492 Shares of AbbVie Inc. $ABBV - MarketBeat
Farmers National Bank Increases Stake in AbbVie Inc. $ABBV - MarketBeat
Alecta Tjanstepension Omsesidigt Buys 110,300 Shares of AbbVie Inc. $ABBV - MarketBeat
AIA Group Ltd Purchases 15,295 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie, Alloy Therapeutics Ink Deal to Develop Next-Gen Antibody Platform - Yahoo Finance
AbbVie (ABBV) looks to deepen its push into rapidly growing obesity-treatment market - MSN
Atopic Dermatitis Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | GlaxoSmithKline PLC, Nestle SA, Pfizer Inc., Regeneron Pharma, Abbvie - Barchart
AbbVie (ABBV) Declines More Than Market: Some Information for Investors - Yahoo Finance
AbbVie Inc. stock underperforms Thursday when compared to competitors - MarketWatch
AbbVie Inc (ABBV) Stock Price, Trades & News - GuruFocus
Buy Or Fear AbbVie Stock At $210? - Forbes
What’s Happening With AbbVie Stock? - Trefis
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie - Benzinga
United Therapeutics or AbbVie: Which Stock Has More Upside? - Trefis
Stillwater Wealth Management Group Takes Position in AbbVie Inc. $ABBV - MarketBeat
Groupama Asset Managment Purchases 10,854 Shares of AbbVie Inc. $ABBV - MarketBeat
Investment Research Partners LLC Buys New Shares in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by CIBC Private Wealth Group LLC - MarketBeat
243,718 Shares in AbbVie Inc. $ABBV Bought by CIBC Bancorp USA Inc. - MarketBeat
Centaurus Financial Inc. Has $3.08 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Allworth Financial LP Acquires 30,124 Shares of AbbVie Inc. $ABBV - MarketBeat
Achmea Investment Management B.V. Has $84.36 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. Stock (ISIN: US00287Y1091) Faces Pressure Amid Recent Pullback: Key Drivers and Investor - AD HOC NEWS
Assessing AbbVie (ABBV) Valuation After The Recent Share Price Pullback - Yahoo Finance
What's Going On With AbbVie Stock Today?AbbVie (NYSE:ABBV) - Benzinga
AbbVie Inc. stock underperforms Wednesday when compared to competitors - MSN
AbbVie (NYSE:ABBV) Trading Down 5.1%Here's Why - MarketBeat
AbbVie (ABBV) Stock Drops 5% After FDA Approves J&J’s Competing Psoriasis Drug - CoinCentral
AbbVie (ABBV) Faces New Competition from J&J's Icotyde Approval - GuruFocus
AbbVie Inc. (ABBV) is attracting investor attention: Here is what you should know - MSN
J&J’s new psoriasis pill to rival AbbVie’s Skyrizi: BNP Paribas - Seeking Alpha
AbbVie (ABBV) slides as investors weigh policy-related pricing risk and recent financing activity - Quiver Quantitative
What triggered AbbVie shares' latest price pullback - Traders Union
AbbVie, Philip Morris among market cap stock movers on Wednesday - Investing.com
Weak momentum, oversold signals: AbbVie stock slides 3.70% - Traders Union
AbbVie Inc Stock (ABBV) Moved Down by 4.60% on Mar 18: A Full Analysis - TradingKey
AbbVie Stock: EPS Set to Jump 45% in 2026 as Skyrizi and Rinvoq Dominate IBD - TIKR.com
AbbVie Inc. $ABBV Shares Sold by Wilmington Savings Fund Society FSB - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Sunbelt Securities Inc. - MarketBeat
Danske Bank A S Invests $279.61 Million in AbbVie Inc. $ABBV - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Has $31.89 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Captrust Financial Advisors Boosts Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Balances False Claims Act Risks With Alloy Antibody Collaboration - simplywall.st
Advisory Services Network LLC Trims Holdings in AbbVie Inc. $ABBV - MarketBeat
Can We Find Cures Faster? - AbbVie
ABBV Stock Quote Price and Forecast - CNN
AbbVie Inc. (ABBV): Billionaire Ken Fisher admires this pharma stock - MSN
AbbVie Inc. (ABBV): Billionaire Ken Fisher Admires This Pharma Stock - Insider Monkey
AbbVie Slips Below 50-Day SMA: Buy, Sell or Hold the Stock? - Yahoo Finance
Alloy Therapeutics and Abbvie partner on antibody platform - BioWorld MedTech
AbbVie Inc. $ABBV Shares Purchased by Mirabella Financial Services LLP - MarketBeat
Mariner LLC Purchases 175,406 Shares of AbbVie Inc. $ABBV - MarketBeat
US FDA declines to approve Aldeyra's eye disorder drug, shares slump - Reuters
Morse Asset Management Inc Grows Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Stock Holdings Trimmed by Mercer Global Advisors Inc. ADV - MarketBeat
AbbVie price tries to vent off oversold saturationForecast today17-03-2026 - Economies.com
2.82%
자본화:
|
볼륨(24시간):